PHA-793887

PHA-793887 · Nerviano Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PHA-793887, covering 2009-10-16 to 2009-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]